This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cools, M. Articles by Looijenga, L. H. J. Search for Related Content PubMed PubMed Citation Articles by Cools, M. Articles by Looijenga, L. H. J. Related Collections Endocrine Oncology Male Endocrinology

Morphological and Immunohistochemical Differences between Gonadal Maturation Delay and Early Germ Cell Neoplasia in Patients with Undervirilization Syndromes

Department of Pathology (M.C., K.v.A., A.-M.K., M.B., J.W.O., L.H.J.L.), Erasmus MC, University Medical Center Rotterdam, Daniel den Hoed, Josephine Nefkens Institute, 3000 DR Rotterdam, The Netherlands; Departments of Pediatric Endocrinology (S.L.S.D.) and Pediatric Urology (K.P.W.), Erasmus MC, University Medical Center Rotterdam, 3000 CB Sophia, The Netherlands; and Center for Clinical Decision Sciences (E.W.S.), Department of Public Health, Erasmus MC, University Medical Center, 3000 DR Rotterdam, The Netherlands

Address all correspondence and requests for reprints to: Leendert H. J. Looijenga, Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Josephine Nefkens Institute, Room 430b, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. E-mail: l.looijenga{at}erasmusmc.nl.

Context: Maturation delay of germ cells and their progression into carcinoma in situ (CIS) frequently occurs in intersex patients. A developmentally delayed germ cell resembles a CIS cell and displays prolonged expression of immunohistochemical markers used for the diagnosis of CIS. This questions their applicability in young children.

Objective: The objective of the study was the elaboration of tools to distinguish germ cells with maturation delay and CIS.

Design: The design was a qualitative and quantitative analysis of the expression of diagnostic markers for CIS in gonads of young patients with undervirilization syndromes.

Setting: The study was conducted in the pathology department of a university center, specializing in germ cell tumor pathogenesis.

Patients: Fifty-eight formalin-fixed, paraffin-embedded testicular tissue samples of 30 undervirilized patients (1 month to 23 yr of age) were analyzed.

Interventions: Interventions included hematoxylin-eosin staining, immunohistochemistry for octamer binding transcription factor (OCT)3/4, gene encoding the stem cell factor receptor that has tyrosine kinase activity c-KIT, placental/germ alkaline phosphatase (PLAP), testis-specific protein Y encoded (TSPY), and VASA, double staining for OCT3/4 and VASA, with ploidy determination by fluorescent in situ hybridization.

Main Outcome Measure: Maturation delay and CIS are characterized by the staining patterns of the immunohistochemical markers.

Results: CIS was diagnosed in three of 30 patients (10%) and four of 58 gonads (6.9%). Patient age, distribution of OCT3/4-positive cells throughout the gonad, and their position within the seminiferous tubule differ between maturation delay and CIS. Abnormal OCT3/4 and testis-specific protein Y encoded expression appear to be of pathogenetic relevance in the development of these lesions.

Conclusion: The dimorphic expression of OCT3/4 allows distinction between maturation delay and CIS. Studies in larger patient series are essential before a biopsy to evaluate the neoplastic risk can eventually be proposed as an alternative for gonadectomy.

This article has been cited by other articles:

				S. Schubert, K. Kamino, D. Bohm, I. Adham, W. Engel, R. v. Wasielewski, D. Moharregh-Khiabani, G. Mauceri, B. Vaske, A. Meinhardt, et al. TSPY Expression Is Variably Altered in Transgenic Mice with Testicular Feminization Biol Reprod, July 1, 2008; 79(1): 125 - 133. [Abstract] [Full Text] [PDF]

				M. Abdulhadi-Atwan, A. Jean, W. K. Chung, K. Meir, Z. Ben Neriah, G. Stratigopoulos, S. E. Oberfield, I. Fennoy, H. J. Hirsch, A. Bhangoo, et al. Role of a Founder c.201_202delCT Mutation and New Phenotypic Features of Congenital Lipoid Adrenal Hyperplasia in Palestinians J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4000 - 4008. [Abstract] [Full Text] [PDF]

				H. M. Scott, G. R. Hutchison, I. K. Mahood, N. Hallmark, M. Welsh, K. De Gendt, G. Verhoeven, P. O'Shaughnessy, and R. M. Sharpe Role of Androgens in Fetal Testis Development and Dysgenesis Endocrinology, May 1, 2007; 148(5): 2027 - 2036. [Abstract] [Full Text] [PDF]

				M. Cools, S. L. S. Drop, K. P. Wolffenbuttel, J. W. Oosterhuis, and L. H. J. Looijenga Germ Cell Tumors in the Intersex Gonad: Old Paths, New Directions, Moving Frontiers Endocr. Rev., August 1, 2006; 27(5): 468 - 484. [Abstract] [Full Text] [PDF]

				P. A. Lee, C. P. Houk, S. F. Ahmed, I. A. Hughes, and in collaboration with the participants in the Inte Consensus Statement on Management of Intersex Disorders Pediatrics, August 1, 2006; 118(2): e488 - e500. [Full Text] [PDF]

				I A Hughes, C Houk, S F Ahmed, P A Lee, and LWPES/ESPE Consensus Group Consensus statement on management of intersex disorders Arch. Dis. Child., July 1, 2006; 91(7): 554 - 563. [Full Text] [PDF]

				M. Cools, H. Stoop, A.-M. F. Kersemaekers, S. L. S. Drop, K. P. Wolffenbuttel, J.-P. Bourguignon, J. Slowikowska-Hilczer, K. Kula, S. M. H. Faradz, J. W. Oosterhuis, et al. Gonadoblastoma Arising in Undifferentiated Gonadal Tissue within Dysgenetic Gonads J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2404 - 2413. [Abstract] [Full Text] [PDF]

				E. Rajpert-De Meyts Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects Hum. Reprod. Update, May 1, 2006; 12(3): 303 - 323. [Abstract] [Full Text] [PDF]